PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1978 April; 71(4): 275–277.
PMCID: PMC1436532

Therapeutic alteration of immune responses in rheumatoid arthritis: is it relevant?

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (326K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Allison AC, Denman AM, Barnes RD. Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971 Jul 17;2(7716):135–140. [PubMed]
  • Berry H, Liyanage SP, Durance RA, Barnes CG, Berger LA, Evans S. Azathioprine and penicillamine in treatment of rheumatoid arthritis: a controlled trial. Br Med J. 1976 May 1;1(6017):1052–1054. [PMC free article] [PubMed]
  • Campbell AC, Skinner JM, Maclennan IC, Hersey P, Waller CA, Wood J, Jewell DP, Truelove SC. Immunosuppression in the treatment of inflammatory bowel disease. II. The effects of azathioprine on lymphoid cell populations in a double blind trial in ulcerative colitis. Clin Exp Immunol. 1976 May;24(2):249–258. [PubMed]
  • Chanmougan D, Schwartz RS. Enhancement of antibody synthesis by 6-mercaptopurine. J Exp Med. 1966 Sep 1;124(3):363–378. [PMC free article] [PubMed]
  • Currey HL, Harris J, Mason RM, Woodland J, Beveridge T, Roberts CJ, Vere DW, Dixon AS, Davies J, Owen-Smith B. Comparison of azathioprine, cyclophosphamide, and gold in treatment of rheumatoid arthritis. Br Med J. 1974 Sep 28;3(5934):763–766. [PMC free article] [PubMed]
  • De Cree J, Verhaegen H, De Cock W, Vanheule R, Brugmans J, Schuermans V. Letter: Impaired neutrophil phagocytosis. Lancet. 1974 Aug 3;2(7875):294–295. [PubMed]
  • Harpey JP, Caille B, Moulias R, Goust JM. Lupus-like syndrome induced by D-penicillamine in Wilson's disease. Lancet. 1971 Feb 6;1(7693):292–292. [PubMed]
  • Hurd ER, Ziff M. Parameters of improvement in patients with rheumatoid arthritis treated with cyclophosphamide. Arthritis Rheum. 1974 Jan-Feb;17(1):72–78. [PubMed]
  • Huskisson EC, Scott J, Balme HW, Dieppe PA, Trapnell J, Willoughby DA. Immunostimulant therapy with levamisole for rheumatoid arthritis. Lancet. 1976 Feb 21;1(7956):393–395. [PubMed]
  • Jessop JD, Currey HL. Influence of gold salts on adjuvant arthritis in the rat. Ann Rheum Dis. 1968 Nov;27(6):577–581. [PMC free article] [PubMed]
  • Oliveira Lima A, Javierre MQ, Dias da Silva W, Sette Camara D. Immunological phagocytosis: effect of drugs on phosphodiesterase activity. Experientia. 1974 Aug 15;30(8):945–946. [PubMed]
  • Ramot B, Biniaminov M, Shoham C, Rosenthal E. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease. N Engl J Med. 1976 Apr 8;294(15):809–811. [PubMed]
  • Weissmann G. Lysosomal mechanisms of tissue injury in arthritis. N Engl J Med. 1972 Jan 20;286(3):141–147. [PubMed]
  • Zvaifler NJ. The immunopathology of joint inflammation in rheumatoid arthritis. Adv Immunol. 1973;16(0):265–336. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press